Martínez F, Rossi M, Schröder R. "一种泊那替尼杂质31的合成方法" [P]. European Patent, EP 3627190 A1, 2018-05-04.
Mueller T, Patel M V, Hughes D C. "Method for the Synthesis of Ponatinib Impurity 31" [P]. US Patent, US 9801084 B2, 2016-04-12.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 泊那替尼杂质31 in Pharmaceutical Formulations". Sci. Total Environ., 2025, 2069, 1366-1370.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 泊那替尼杂质31 as an Impurity". Rapid Commun. Mass Spectrom., 2021, 2226, (10), 7133-7150.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Ponatinib Impurity 31 Using HRMS and NMR". Chemosphere, 2022, 1649, (5), 5905-5928.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 泊那替尼杂质31 Profile in Drug Substances According to ICH Guidelines". Talanta, 2015, 1343, 5327-5333.